Xuening Zhang

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Magnetic Resonance Imaging

Contrast Enhanced

Top Venues

Technology in cancer research & treatment

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Yu Ji, Heather M Whitney, Hui Li, Peifang Liu, Maryellen L Giger, Xuening Zhang
Differences in Molecular Subtype Reference Standards Impact AI-based Breast Cancer Classification with Dynamic Contrast-enhanced MRI. Radiology (2023)
Xiaoyi Wang, Min Ma, Liang Zhang, Xiaoran Wang, Yimou Zhang, Yang Zhao, Huilan Shi, Xuening Zhang, Fangshi Zhao, Jinbing Pan
Flexible use of commercial rhenium disulfide for various theranostic applications. Biomaterials science (2023)
Yu Ji, Heather M Whitney, Hui Li, Peifang Liu, Maryellen L Giger, Xuening Zhang
Differences in Molecular Subtype Reference Standards Impact AI-based Breast Cancer Classification with Dynamic Contrast-enhanced MRI. Radiology (2023)
Yu Ji, Heather M Whitney, Hui Li, Peifang Liu, Maryellen L Giger, Xuening Zhang
Differences in Molecular Subtype Reference Standards Impact AI-based Breast Cancer Classification with Dynamic Contrast-enhanced MRI. Radiology (2023)
Lingwei Wang, Mengyang Zhang, Xujie Gao, Jiang Li, Menglin Wu, Xuening Zhang, Zhaoxiang Ye
Multifunctional nanoprobes combined with radiotherapy and hypoxia-activated therapy synergistically improve antitumor efficacy. RSC advances 12 (50) (2022)
Xue Li, Jiang Li, Chunyin Li, Qi Guo, Menglin Wu, Lin Su, Yan Dou, Xinhong Wu, Zhaoxun Xiao, Xuening Zhang
Aminopeptidase N-targeting nanomolecule-assisted delivery of VEGF siRNA to potentiate antitumour therapy by suppressing tumour revascularization and enhancing radiation response. Journal of materials chemistry. B 9 (36) (2021)
Guoping Xu, Yungang Zhu, Huijia Liu, Yingying Liu, Xuening Zhang
Long Non-Coding RNA KCNQ1OT1 Promotes Progression of Hepatocellular Carcinoma by miR-148a-3p/IGF1R Axis. Technology in cancer research & treatment 19 (2021)
Jianwen Hao, Qizhen Peng, Keruo Wang, Ge Yu, Yi Pan, Xiaoling Du, Na Hu, Xuening Zhang, Yu Qin, Huikai Li
Antitumor Effect of Lenvatinib Combined with Alisertib in Hepatocellular Carcinoma by Targeting the DNA Damage Pathway. BioMed research international 2021 (2021)